Open AccessJAK1/2 Inhibitors Linked to Aggressive B-cell Lymphoma Risk in Myelofibrosis and Pre-existing B-cell Clones May Mark Those at Risk
Author(s) -
Sioḃán Keel
Publication year - 2018
Publication title -
the hematologist
Language(s) - English
Resource type - Journals
ISSN - 1551-8779
DOI - 10.1182/hem.v15.5.8922
Subject(s) - myelofibrosis , cancer research , lymphoma , oncology , cell , b cell , medicine , b cell lymphoma , biology , genetics , immunology , bone marrow , antibody